International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
Fonseca, R, Bergsagel, P L, Drach, J, Shaughnessy, J, Gutierrez, N, Stewart, A K, Morgan, G, Van Ness, B, Chesi, M, Minvielle, S, Neri, A, Barlogie, B, Kuehl, W M, Liebisch, P, Davies, F, Chen-Kiang, S, Durie, B G M, Carrasco, R, Sezer, Orhan, Reiman, Tony, Pilarski, Linda, Avet-Loiseau, H
Published in Leukemia (01.12.2009)
Published in Leukemia (01.12.2009)
Get full text
Journal Article
Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma
Chng, W-J, Huang, G F, Chung, T H, Ng, S B, Gonzalez-Paz, N, Troska-Price, T, Mulligan, G, Chesi, M, Bergsagel, P L, Fonseca, R
Published in Leukemia (01.06.2011)
Published in Leukemia (01.06.2011)
Get full text
Journal Article
Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trial
Reeder, C B, Reece, D E, Kukreti, V, Chen, C, Trudel, S, Hentz, J, Noble, B, Pirooz, N A, Spong, J E, Piza, J G, Zepeda, V H J, Mikhael, J R, Leis, J F, Bergsagel, P L, Fonseca, R, Stewart, A K
Published in Leukemia (01.07.2009)
Published in Leukemia (01.07.2009)
Get full text
Journal Article
Genetic aberrations and survival in plasma cell leukemia
Tiedemann, R E, Gonzalez-Paz, N, Kyle, R A, Santana-Davila, R, Price-Troska, T, Van Wier, S A, Chng, W J, Ketterling, R P, Gertz, M A, Henderson, K, Greipp, P R, Dispenzieri, A, Lacy, M Q, Rajkumar, S V, Bergsagel, P L, Stewart, A K, Fonseca, R
Published in Leukemia (01.05.2008)
Published in Leukemia (01.05.2008)
Get full text
Journal Article
Pomalidomide (CC4047) plus low dose dexamethasone (Pom dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM)
Lacy, M Q, Hayman, S R, Gertz, M A, Short, K D, Dispenzieri, A, Kumar, S, Greipp, P R, Lust, J A, Russell, S J, Dingli, D, Zeldenrust, S, Fonseca, R, Bergsagel, P L, Roy, V, Mikhael, J R, Stewart, A K, Laumann, K, Allred, J B, Mandrekar, S J, Rajkumar, S V, Buadi, F
Published in Leukemia (01.11.2010)
Published in Leukemia (01.11.2010)
Get full text
Journal Article
Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myeloma
FONSECA, R, VAN WIER, S. A, PRICE-TROSKA, T, HENDERSON, K. J, AHMANN, G. J, GERTZ, M. A, CHNG, W. J, KETTERLING, R, LACY, M. Q, DISPENZIERI, A, BERGSAGEL, P. L, RAJKUMAR, S. V, GREIPP, P. R, LITZOW, M. R
Published in Leukemia (01.11.2006)
Published in Leukemia (01.11.2006)
Get full text
Journal Article
Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276
Schmidt, J, Braggio, E, Kortuem, K M, Egan, J B, Zhu, Y X, Xin, C S, Tiedemann, R E, Palmer, S E, Garbitt, V M, McCauley, D, Kauffman, M, Shacham, S, Chesi, M, Bergsagel, P L, Stewart, A K
Published in Leukemia (01.12.2013)
Published in Leukemia (01.12.2013)
Get full text
Journal Article
A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy
STEWART, A. K, BERGSAGEL, P. L, WITZIG, T. E, ZELDENRUST, S. R, DINGLI, D, REEDER, C. B, ROY, V, KYLE, R. A, RAJKUMAR, S. V, FONSECA, R, GREIPP, P. R, DISPENZIERI, A, GERTZ, M. A, HAYMAN, S. R, KUMAR, S, LACY, M. Q, LUST, J. A, RUSSELL, S. J
Published in Leukemia (01.03.2007)
Published in Leukemia (01.03.2007)
Get full text
Journal Article
Carfilzomib and the cardiorenal system in myeloma: an endothelial effect?
Rosenthal, A, Luthi, J, Belohlavek, M, Kortüm, K M, Mookadam, F, Mayo, A, Fonseca, R, Bergsagel, P L, Reeder, C B, Mikhael, J R, Stewart, A K
Published in Blood cancer journal (New York) (01.01.2016)
Published in Blood cancer journal (New York) (01.01.2016)
Get full text
Journal Article
Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations
CHNG, W. J, SANTANA-DAVILA, R, OKEN, M. M, HENDERSON, K, KYLE, R. A, GERTZ, M. A, LACY, M. Q, DISPENZIERI, A, GREIPP, P. R, FONSECA, R, VAN WIER, S. A, AHMANN, G. J, JALAL, S. M, BERGSAGEL, P. L, CHESI, M, TRENDLE, M. C, JACOBUS, S, BLOOD, E
Published in Leukemia (01.05.2006)
Published in Leukemia (01.05.2006)
Get full text
Journal Article
Pomalidomide–dexamethasone in refractory multiple myeloma: long-term follow-up of a multi-cohort phase II clinical trial
Ailawadhi, S, Mikhael, J R, LaPlant, B R, Laumann, K M, Kumar, S, Roy, V, Dingli, D, Bergsagel, P L, Buadi, F K, Rajkumar, S V, Fonseca, R, Gertz, M A, Kapoor, P, Sher, T, Hayman, S R, Stewart, A K, Dispenzieri, A, Kyle, R A, Gonsalves, W I, Reeder, C B, Lin, Y, Go, R S, Leung, N, Kourelis, T, Lust, J A, Russell, S J, Chanan-Khan, A A, Lacy, M Q
Published in Leukemia (01.03.2018)
Published in Leukemia (01.03.2018)
Get full text
Journal Article
Characterization of MYC translocations in multiple myeloma cell lines
Dib, Amel, Gabrea, Ana, Glebov, Oleg K, Bergsagel, P Leif, Kuehl, W Michael
Published in Journal of the National Cancer Institute. Monographs (01.07.2008)
Published in Journal of the National Cancer Institute. Monographs (01.07.2008)
Get more information
Journal Article
Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3
Chesi, Marta, Nardini, Elena, Brents, Leslie A, Schröck, Evelin, Ried, Thomas, Kuehl, W. Michael, Bergsagel, P. Leif
Published in Nature genetics (01.07.1997)
Published in Nature genetics (01.07.1997)
Get full text
Journal Article
Correlation between array-comparative genomic hybridization-defined genomic gains and losses and survival: identification of 1p31-32 deletion as a prognostic factor in myeloma
Chng, W J, Gertz, M A, Chung, T-H, Van Wier, S, Keats, J J, Baker, A, Bergsagel, P L, Carpten, J, Fonseca, R
Published in Leukemia (01.04.2010)
Published in Leukemia (01.04.2010)
Get full text
Journal Article
Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapy
Kumar, S K, Mikhael, J, LaPlant, B, Lacy, M Q, Buadi, F K, Dingli, D, Gertz, M A, Laumann, K, Miceli, T, Mahlman, M, Bergsagel, L P, Hayman, S R, Reeder, C, Stewart, A K, Dispenzieri, A, Gastineau, D A, Winters, J L
Published in Bone marrow transplantation (Basingstoke) (01.02.2014)
Published in Bone marrow transplantation (Basingstoke) (01.02.2014)
Get full text
Journal Article
Advances in the pathogenesis and diagnosis of multiple myeloma
Chesi, M., Bergsagel, P. L.
Published in International journal of laboratory hematology (01.05.2015)
Published in International journal of laboratory hematology (01.05.2015)
Get full text
Journal Article
Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma
Affer, M, Chesi, M, Chen, W D, Keats, J J, Demchenko, Y N, Tamizhmani, K, Garbitt, V M, Riggs, D L, Brents, L A, Roschke, A V, Van Wier, S, Fonseca, R, Bergsagel, P L, Kuehl, W M
Published in Leukemia (01.08.2014)
Published in Leukemia (01.08.2014)
Get full text
Journal Article
Frequent inactivation of the cyclin-dependent kinase inhibitor p18 by homozygous deletion in multiple myeloma cell lines: ectopic p18 expression inhibits growth and induces apoptosis
KULKARNI, M. S, DAGGETT, J. L, BENDER, T. P, KUEHL, W. M, BERGSAGEL, P. L, WILLIAMS, M. E
Published in Leukemia (2002)
Published in Leukemia (2002)
Get full text
Journal Article